About
PolyNovo Limited is an Australian public medical device company based in Port Melbourne, Victoria. Founded in 1998, the company specializes in developing, manufacturing, and commercializing surgical solutions using its proprietary bioabsorbable polymer technology, NovoSorb®. This technology is designed for advanced wound care and tissue repair, with products that biodegrade safely in the body to support healing. The flagship product, NovoSorb BTM (Biodegradable Temporizing Matrix), is a temporary skin substitute for treating full-thickness burns and complex wounds. It received FDA 510(k) clearance in 2015 and has been supported by funding from the US Biomedical Advanced Research and Development Authority (BARDA) for clinical trials. PolyNovo serves hospitals, burn centers, and healthcare providers globally, with significant sales growth in the United States, Australia, and New Zealand. In 2024, the company reported total revenue of approximately AUD 104.8 million, reflecting strong market acceptance of its innovative technologies.
Technologies
Keywords
Company Information
-
Employees 290
-
Annual Revenue $83186000
Location
320 Lorimer Street, Port Melbourne, Victoria, Australia, 3207
